Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.
- DOI
- 10.57264/cer-2023-0194
- Published
- 2024 Aug
- Container
- Journal of comparative effectiveness research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.57264/cer-2023-0194,
title = {Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.},
author = {Stewart EA and Lukes AS and Venturella R and Li Y and Hunsche E and Wagman RB and Al-Hendy A},
year = {2024},
journal = {Journal of comparative effectiveness research},
doi = {10.57264/cer-2023-0194},
url = {https://doi.org/10.57264/cer-2023-0194}
}RIS
TY - JOUR TI - Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. AU - Stewart EA AU - Lukes AS AU - Venturella R AU - Li Y AU - Hunsche E AU - Wagman RB AU - Al-Hendy A PY - 2024 JO - Journal of comparative effectiveness research DO - 10.57264/cer-2023-0194 UR - https://doi.org/10.57264/cer-2023-0194 ER -
APA
EA, S., AS, L., R, V., Y, L., E, H., RB, W., & A, A. (2024). Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.. Journal of comparative effectiveness research. https://doi.org/10.57264/cer-2023-0194
Source records
- pubmed · retrieved 2026-09-25T23:44:05.429Z